AZN, Daiichi's Datroway Wins FDA Nod for Expanded Use in Breast Cancer
AstraZeneca and Daiichi Sankyo get FDA approval for Datroway's expanded use in triple-negative breast cancer treatment.
Open original sourceLoading market dashboard
AstraZeneca and Daiichi Sankyo get FDA approval for Datroway's expanded use in triple-negative breast cancer treatment.
Open original source